Resilience
Biologics and sterile drug product CDMO for biotech and pharma companies, from clinical batches to commercial supply
Highlights
- New on EvolcAdded 2026-11-11
About Resilience
Resilience is a contract development and manufacturing organization (CDMO) for biologics and sterile drug products. Its services cover biologics drug substance in single-use bioreactors up to 2,000L, formulation and aseptic filling of vials, prefilled syringes and cartridges, automated visual inspection, device assembly, labeling, packaging, serialization and cold-chain logistics.
Customers are biotech and pharma companies at every stage, from first clinical batches to commercial launch. Work is organized by program, with a dedicated program manager and technical lead for each engagement.
Resilience was founded in 2020 and is headquartered in Blue Ash, Ohio. Its North American network includes a 580,000 sq ft sterile drug product site in West Chester, Ohio, and a site in Toronto, Ontario. Open roles listed include manufacturing and maintenance technicians, process and automation engineers, and quality assurance specialists, mostly in Ohio.
Product: Contract manufacturing of biologics drug substance and sterile drug product, with device assembly, labeling, packaging and serialization.
Jobs at Resilience
More biotech & pharma companies
Rho
Clinical trial services for drug, biologic and device sponsors, from regulatory strategy to biometrics and trial executionRemote-friendlyRoivant Sciences
Develops and commercializes medicines and health technologies through focused subsidiary companiesNew on EvolcSaphobio
Rapid pharmaceutical release testing services for compounding pharmacies and pharmaceutical manufacturersNew on EvolcSarepta
Develops genetic medicines for rare diseases, including neuromuscular conditions, for patients and healthcare providersRemote-friendlySalary transparentSeaport Therapeutics
Develops medicines for patients with depression, anxiety and other neuropsychiatric disordersNew on EvolcSepterna
Develops oral small-molecule drugs for GPCR targets in endocrinology, immunology and metabolic diseaseNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Response headerserver
- Response headerserver
Content management
- HubSpot CMSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
CRM & customer data
- HubSpotMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.